These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9165550)

  • 1. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
    Min DI; Chen HY; Lee MK; Ashton K; Martin MF
    Pharmacotherapy; 1997; 17(3):457-63. PubMed ID: 9165550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian and time-dependent variability in tacrolimus pharmacokinetics.
    Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation of tacrolimus disposition in liver allograft recipients.
    Min DI; Chen HY; Fabrega A; Ukah FO; Wu YM; Corwin C; Ashton MK; Martin M
    Transplantation; 1996 Oct; 62(8):1190-2. PubMed ID: 8900327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy.
    Mendonza AE; Zahir H; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Aug; 29(4):391-8. PubMed ID: 17667791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
    Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
    Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK; Park JM; Lake KD
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
    Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
    Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
    Kaplan B; Meier-Kriesche HU; Napoli KL; Kahan BD
    Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.